Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.

The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a ...

US approves breakthrough HIV jab – but aid cuts mean it may not get to millions in need - FDA approval paves the way for the ...

A twice-yearly injectable drug for the prevention of HIV infection has been approved by the United States’ Food and Drug ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

A drug with the potential to drastically curb the HIV epidemic just cleared its first regulatory hurdle. On Wednesday, the Food and Drug Administration approved lenacapavir for the prevention of HIV.

On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...

FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant ...

The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.

A major win in the fight against HIV infections. The Food and Drug Administration approved a new twice-a-year shot to prevent ...

Lenacapavir is an antiretroviral medicine that helps prevent 99.9 per cent of all HIV transmission, according to studies.

The U.S. approved a twice-yearly HIV prevention shot that’s highly effective, but concerns about cost, access, and global ...